MetaCap

Core Scientific Cash Flow Statement

NASDAQ: CORZFinanceFinance: Consumer ServicesUSD

15.41+0.05 (+0.33%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Core Scientific free cash flow

In fiscal 2025, Core Scientific generated $278.3 million of operating cash flow and spent $729.0 million on capital expenditures. That left free cash flow of -$450.8 million, a free-cash-flow margin of -141.3% of revenue.

Summary generated from market data by MetaCap's automated system. Methodology

Core Scientific cash flow statement (annual)

Core Scientific annual cash flow statement
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20222022-12-31FY 20212021-12-31FY 20202020-12-31
Net Income-288.62M-1.44B-246.49M-2.15B-32.50M-12.21M
Net Income growth (YoY)——————
Depreciation & Amortization68.91M113.20M96.00M225.26M33.36M9.40M
Stock-Based Compensation98.24M51.92M58.89M182.89M38.94M3.04M
Change in Working Capital-6.62M-9.73M248.53M104.39M177.05M26.21M
Operating Cash Flow278.25M42.90M65.11M205.19M-56.73M-23.77M
Capital Expenditures-729.00M-94.96M-16.16M-383.98M00
Investing Cash Flow-740.75M-95.19M-3.00M-590.78M-423.84M-15.14M
Share Repurchases—00-31.65M——
Debt Issued—00261.35M670.75M45.18M
Debt Repaid-8.61M-304.82M-40.99M-113.29M-49.28M-5.27M
Financing Cash Flow-63.10M819.57M-44.65M306.15M603.53M40.72M
Net Change in Cash-525.60M767.27M17.47M-79.44M122.96M1.81M
Free Cash Flow-450.75M-52.06M48.95M-178.79M-56.73M-23.77M

This table shows 6 annual periods of Core Scientific's cash flow statement, from FY 2025 back to FY 2020, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow CORZ's reporting calendar. What is a cash flow statement?

More financial data